FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used for simulation of retinal pigment epithelium atrophy. Solution is injected into the subretinal space to form a subretinal bladder. Solution used is 0.9 % sodium chloride in amount of 0.03 ml, which is introduced at 0.5 pd below the optic disc.
EFFECT: method provides an adequate clinical-functional and morphological model of retinal pigment epithelium atrophy, reflecting the closest natural process to the natural process, by introducing 0_9 % sodium chloride solution into subretinal space to form a subretinal bladder, which leads to irreversible changes in the form of degeneration of the photoreceptor retinal layer and atrophy of retinal pigment epithelium.
1 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2709247C1 |
| METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
| METHOD OF TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM INDUCED HUMAN PLURIPOTENT STEM CELLS, WITH RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2730937C1 |
| METHOD OF EVALUATING RETINA FUNCTIONING | 2008 |
|
RU2363370C1 |
| METHOD FOR DETERMINING THE EXPRESSION LEVEL OF THE GENE ENCODING VEGF-A IN THE EYE TISSUES OF THE ORYCTOLAGUS CUNICULUS RABBIT, AND A KIT FOR ITS DETERMINATION | 2021 |
|
RU2761339C1 |
| METHOD FOR DETERMINING GENE EXPRESSION LEVEL, CODING PEDF, IN ORYCTOLAGUS CUNICULUS RABBIT EYE TISSUES AND A KIT FOR ITS DETERMINING | 2021 |
|
RU2765437C1 |
| METHOD FOR DETECTING AN ACTIVE DESTRUCTIVE PROCESS IN THE RETINA IN AN EXPERIMENT | 2021 |
|
RU2768588C1 |
| METHOD FOR DETERMINING LEVEL OF EXPRESSION OF GENE CODING ZO-1 IN EYE TISSUES OF RABBIT ORYCTOLAGUS CUNICULUS AND KIT FOR DETERMINING THEREOF | 2021 |
|
RU2766186C1 |
| METHOD FOR IMPROVING FUNCTIONAL RETINA ACTIVITY IN THE CASES OF ITS ABNORMALITY OF VARIOUS GENESIS | 2004 |
|
RU2279886C2 |
| METHOD FOR DETERMINING INDICATIONS FOR ANTIANGIOGENIC THERAPY IN CASE OF SUSPICION OF WET FORM OF AGE-RELATED MACULAR DEGENERATION | 2021 |
|
RU2758662C1 |
